These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2574802)

  • 1. ACE inhibitors after myocardial infarction.
    Hall AS; Ball SG
    Lancet; 1989 Dec 23-30; 2(8678-8679):1527. PubMed ID: 2574802
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ambulatory multicenter study of Triatec (ramipril). Observations concerning the lessons of the trial for the realization of future trials and for the management of hypertensive patients].
    Battaglia C; Gallet M; Carré A
    Rev Prat; 1990 Jun; 40(18 Suppl):45-7. PubMed ID: 2143598
    [No Abstract]   [Full Text] [Related]  

  • 3. An open multicenter study to assess the long-term efficacy, tolerance, and safety of the oral angiotensin converting enzyme inhibitor ramipril in patients with mild to moderate essential hypertension.
    Bauer B; Lorenz H; Zahlten R
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S70-4. PubMed ID: 2474109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acronyms and myocardial infarction studies.
    Cheng TO
    Clin Cardiol; 1992 Apr; 15(4):A27. PubMed ID: 1532928
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute effects of the angiotensin converting enzyme inhibitor ramipril in patients with coronary heart disease].
    Unterberg C; Buchwald A; Vogt A; Wiegand V
    Med Klin (Munich); 1990 Feb; 85(2):78-81. PubMed ID: 2138704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change in cough reflex after treatment with enalapril and ramipril.
    McEwan JR; Choudry N; Street R; Fuller RW
    BMJ; 1989 Jul; 299(6690):13-6. PubMed ID: 2547470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renin-angiotensin system and ramipril, a new converting enzyme inhibitor.
    Vasmant D; Bender N
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S46-52. PubMed ID: 2483429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of Triatec in monotherapy and in combination with Lasilix in a French multicenter study].
    Guyot D; Lemarié JC
    Rev Prat; 1990 Jun; 40(18 Suppl):27-30, 35-8. PubMed ID: 2143596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The French ambulatory multicenter trial of Triatec: conclusions of the trial].
    Le Menn G
    Rev Prat; 1990 Jun; 40(18 Suppl):48-50. PubMed ID: 2143599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [French multicenter study of Triatec (ramipril) in ambulatory patients: methodology and trial structure].
    Vasmant D; Thiéry P
    Rev Prat; 1990 Jun; 40(18 Suppl):21-6. PubMed ID: 2143595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disappearance of captopril-induced taste disturbance after substitution with angiotensin-converting-enzyme inhibitor HOE 498.
    Mauersberger H; Witte PU
    Lancet; 1985 Mar; 1(8427):517-8. PubMed ID: 2857878
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blind study to compare the efficacy, tolerance and safety of two doses of the angiotensin converting enzyme inhibitor ramipril with placebo.
    Villamil AS; Cairns V; Witte PU; Bertolasi CA
    Am J Cardiol; 1987 Apr; 59(10):110D-114D. PubMed ID: 3034017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of an angiotensin converting enzyme inhibitor, ramipril, on bronchial responses to inhaled histamine and bradykinin in asthmatic subjects.
    Dixon CM; Fuller RW; Barnes PJ
    Br J Clin Pharmacol; 1987 Jan; 23(1):91-3. PubMed ID: 3028458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First dose response and 24-hour antihypertensive efficacy of the new once-daily angiotensin converting enzyme inhibitor, ramipril.
    Heber ME; Brigden GS; Caruana MP; Lahiri A; Raftery EB
    Am J Cardiol; 1988 Aug; 62(4):239-45. PubMed ID: 2969671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of a new angiotensin-converting enzyme inhibitor, ramipril, vs. enalapril in essential hypertension: a multicenter trial.
    Mroczek WJ
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S147-9. PubMed ID: 1725028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology of ramipril.
    Ball SG; Robertson JI
    Am J Cardiol; 1987 Apr; 59(10):23D-27D. PubMed ID: 3034028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short- and long-term effects of ramipril in hypertension.
    de Leeuw PW; Birkenhäger WH
    Am J Cardiol; 1987 Apr; 59(10):79D-82D. PubMed ID: 3034038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic properties of ramipril in patients with congestive heart failure (NYHA III-IV).
    Gerckens U; Grube E; Mengden T; Sigel H; Wagner WL; Lahn T; Irmisch R; Metzger H
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S49-51. PubMed ID: 2474102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of response rates to the angiotensin-converting enzyme inhibitor ramipril in mild-to-moderate hypertension in a double-blind, parallel-group study and an open single-blind study.
    Vasmant D; Lendresse P; Lemarie JC; Gallet M
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S144-6. PubMed ID: 1725027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of left ventricular hypertrophy under ramipril treatment investigated by nuclear magnetic resonance imaging.
    Eichstaedt H; Danne O; Langer M; Cordes M; Schubert C; Felix R; Schmutzler H
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S75-80. PubMed ID: 2474110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.